Literature DB >> 19941004

Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway.

Tatiana Victoni1, Fernando Rodrigues Coelho, Alexandre Learth Soares, Andressa de Freitas, Thomas Secher, Rodrigo Guabiraba, François Erard, Ricardo Martins de Oliveira-Filho, B Boris Vargaftig, Gregoire Lauvaux, Mamdouh A Kamal, Bernhard Ryffel, René Moser, Wothan Tavares-de-Lima.   

Abstract

Innate immune responses against microorganisms may be mediated by Toll-like receptors (TLRs). Intestinal ischemia-reperfusion (i-I/R) leads to the translocation of bacteria and/or bacterial products such as endotoxin, which activate TLRs leading to acute intestinal and lung injury and inflammation observed upon gut trauma. Here, we investigated the role of TLR activation by using mice deficient for the common TLR adaptor protein myeloid differentiation factor 88 (MyD88) on local and remote inflammation following intestinal ischemia. Balb/c and MyD88(-/-) mice were subjected to occlusion of the superior mesenteric artery (45 min) followed by intestinal reperfusion (4 h). Acute neutrophil recruitment into the intestinal wall and the lung was significantly diminished in MyD88(-/-) after i-I/R, which was confirmed microscopically. Diminished neutrophil recruitment was accompanied with reduced concentration of TNF-alpha and IL-1beta level. Furthermore, diminished microvascular leak and bacteremia were associated with enhanced survival of MyD88(-/-) mice. However, neither TNF-alpha nor IL-1beta neutralization prevented neutrophil recruitment into the lung but attenuated intestinal inflammation upon i-I/R. In conclusion, our data demonstrate that disruption of the TLR/MyD88 pathway in mice attenuates acute intestinal and lung injury, inflammation, and endothelial damage allowing enhanced survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941004     DOI: 10.1007/s00430-009-0134-5

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  31 in total

Review 1.  How dying cells alert the immune system to danger.

Authors:  Hajime Kono; Kenneth L Rock
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

Review 2.  Pathophysiology and implications for treatment of acute respiratory distress syndrome.

Authors:  M H van Soeren; W L Diehl-Jones; R J Maykut; W M Haddara
Journal:  AACN Clin Issues       Date:  2000-05

3.  Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.

Authors:  Yuan Zhai; Xiu-da Shen; Ryan O'Connell; Feng Gao; Charles Lassman; Ronald W Busuttil; Genhong Cheng; Jerzy W Kupiec-Weglinski
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

Review 4.  New cellular and molecular immune pathways in ischemia/reperfusion injury.

Authors:  P Boros; J S Bromberg
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

5.  The essential role of the intestinal microbiota in facilitating acute inflammatory responses.

Authors:  Danielle G Souza; Angélica T Vieira; Adriana C Soares; Vanessa Pinho; Jacques R Nicoli; Leda Q Vieira; Mauro M Teixeira
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

6.  The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats.

Authors:  Tomomi Suzuki; Kenichiro Yamashita; Wataru Jomen; Shinya Ueki; Takeshi Aoyagi; Moto Fukai; Hiroyuki Furukawa; Kazuo Umezawa; Michitaka Ozaki; Satoru Todo
Journal:  J Surg Res       Date:  2008-02-29       Impact factor: 2.192

7.  Lung injury after ischemia-reperfusion of small intestine in rats involves apoptosis of type II alveolar epithelial cells mediated by TNF-alpha and activation of Bid pathway.

Authors:  Shucai An; Yoshitaka Hishikawa; Jie Liu; Takehiko Koji
Journal:  Apoptosis       Date:  2007-11       Impact factor: 4.677

8.  A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.

Authors:  Yuxiang Huang; Fei Qiao; Carl Atkinson; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice.

Authors:  D Torres-Dueñas; M R N Celes; A Freitas; J C Alves-Filho; F Spiller; D Dal-Secco; V F Dalto; M A Rossi; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

10.  Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration.

Authors:  P Sorkine; A Setton; P Halpern; A Miller; V Rudick; S Marmor; J M Klausner; G Goldman
Journal:  Crit Care Med       Date:  1995-08       Impact factor: 7.598

View more
  29 in total

1.  TLR signaling prevents hyperoxia-induced lung injury by protecting the alveolar epithelium from oxidant-mediated death.

Authors:  Megan N Ballinger; Michael W Newstead; Xianying Zeng; Urvashi Bhan; Jeffrey C Horowitz; Bethany B Moore; David J Pinsky; Richard A Flavell; Theodore J Standiford
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

3.  Beneficial effect of low-level laser therapy in acute lung injury after i-I/R is dependent on the secretion of IL-10 and independent of the TLR/MyD88 signaling.

Authors:  J L Carvalho; A Britto; A P Ligeiro de Oliveira; H Castro-Faria-Neto; R Albertini; E Anatriello; F Aimbire
Journal:  Lasers Med Sci       Date:  2016-12-06       Impact factor: 3.161

4.  Helicobacter infection alters MyD88 and Trif signalling in response to intestinal ischaemia-reperfusion.

Authors:  Sara M Hoffman; Hua Wang; Michael R Pope; Sherry D Fleming
Journal:  Exp Physiol       Date:  2010-11-05       Impact factor: 2.969

5.  Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.

Authors:  Marc Derive; Frédéric Massin; Sébastien Gibot
Journal:  Self Nonself       Date:  2010-07-02

6.  An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury.

Authors:  Alana A Shigeoka; James L Mueller; Amanpreet Kambo; John C Mathison; Andrew J King; Wesley F Hall; Jean da Silva Correia; Richard J Ulevitch; Hal M Hoffman; Dianne B McKay
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

7.  Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6.

Authors:  Sheng-Zhi Liu; Xue-Mei He; Xu Zhang; Fan-Cai Zeng; Fang Wang; Xiang-Yu Zhou
Journal:  Dig Dis Sci       Date:  2016-08-18       Impact factor: 3.199

8.  Recombinant high-mobility group box 1 protein (HMGB-1) promotes myeloid differentiation primary response protein 88 (Myd88) upregulation in mouse primary cortical neurons.

Authors:  Wei Li; Hai-Ping Ling; Wan-Chun You; Xiang-Jun Ji; Yong Tang; Jin-Bing Zhao; Xing-Fen Su; Chun-Hua Hang
Journal:  Neurol Sci       Date:  2012-06-19       Impact factor: 3.307

9.  TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation.

Authors:  Michael R Pope; Sherry D Fleming
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

10.  TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage.

Authors:  Emily Archer Slone; Michael R Pope; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Am J Clin Exp Immunol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.